Modern Chinese Medicine Group (01643) has issued an announcement stating that the company has noted a publication released by the Securities and Futures Commission on April 14, 2026. Based on available information and to the best of the directors' knowledge after making all reasonable inquiries, the company confirms that, as of March 30, 2026, and the date of this announcement, no less than 25% of the company's issued shares were held by the public. The company asserts it is capable of complying with the public float requirements under the Listing Rules of the Stock Exchange.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments